• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.

作者信息

Charvet E, Bourrat E, Hickman G, Donadieu J, Bellanné-Chantelot C, Jachiet M, Bouaziz J-D, Bagot M, Cassius C

机构信息

Department of Dermatology, Saint-Louis Hospital, AP-HP, 1 avenue Claude Vellefaux, Paris, France.

Department of Pediatrics, Robert Debré Hospital, AP-HP, Paris, France.

出版信息

Clin Exp Dermatol. 2021 Oct;46(7):1334-1335. doi: 10.1111/ced.14686. Epub 2021 Jun 2.

DOI:10.1111/ced.14686
PMID:33864281
Abstract
摘要

相似文献

1
Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.度普利尤单抗治疗携带显性负性CARD11变异的重度特应性皮炎的疗效。
Clin Exp Dermatol. 2021 Oct;46(7):1334-1335. doi: 10.1111/ced.14686. Epub 2021 Jun 2.
2
Prurigo-like atopic dermatitis in a child with CARD11-associated severe combined immunodeficiency successfully treated with dupilumab.卡氏白细胞黏附分子缺陷 11 相关重症联合免疫缺陷患儿的类痒疹样特应性皮炎经度普利尤单抗治疗后成功缓解。
Pediatr Dermatol. 2024 Jan-Feb;41(1):158-159. doi: 10.1111/pde.15453. Epub 2023 Oct 27.
3
Rosacea associated with dupilumab therapy.与度普利尤单抗治疗相关的酒渣鼻。
J Dermatolog Treat. 2021 Feb;32(1):114-116. doi: 10.1080/09546634.2019.1624683. Epub 2019 Jun 9.
4
Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.度普利尤单抗治疗中重度特应性皮炎患者对循环 T 细胞功能的早期和长期影响。
J Invest Dermatol. 2021 Aug;141(8):1943-1953.e13. doi: 10.1016/j.jid.2021.01.022. Epub 2021 Feb 18.
5
DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11.DOK3 通过使磷酸酶 PP4C 抑制 T 细胞信号转导介质 CARD11 来促进特应性皮炎。
Sci Signal. 2023 Oct 31;16(809):eadg5171. doi: 10.1126/scisignal.adg5171.
6
Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.2型炎症：度普利尤单抗成功治疗特应性皮炎、哮喘和高嗜酸性粒细胞增多症。
J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):261-263. doi: 10.18176/jiaci.0614. Epub 2020 Jul 30.
7
Development of Sézary syndrome following the administration of dupilumab.使用度普利尤单抗后发生蕈样肉芽肿综合征。
Dermatol Online J. 2020 Apr 15;26(4):13030/qt1m67z8sb.
8
Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series.度普利尤单抗在6岁以下儿童中用于治疗中度至重度特应性皮炎的超说明书用药：病例系列
Clin Exp Dermatol. 2022 Feb;47(2):423-425. doi: 10.1111/ced.14925. Epub 2021 Oct 19.
9
Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report.度普利尤单抗治疗肝移植受者特应性皮炎的有效性和安全性：一例病例报告
J Dtsch Dermatol Ges. 2020 Jul;18(7):740-742. doi: 10.1111/ddg.14074. Epub 2020 Mar 25.
10
Germline hypomorphic CARD11 mutations in severe atopic disease.严重特应性疾病中的种系低表达CARD11突变
Nat Genet. 2017 Aug;49(8):1192-1201. doi: 10.1038/ng.3898. Epub 2017 Jun 19.

引用本文的文献

1
From syndromic clues to diagnosis: understanding CARD11-driven disorders.从综合征线索到诊断：了解CARD11驱动的疾病。
Front Immunol. 2025 Jun 23;16:1626065. doi: 10.3389/fimmu.2025.1626065. eCollection 2025.
2
The genetics of hyper IgE syndromes.高免疫球蛋白E综合征的遗传学
Front Immunol. 2025 Feb 18;16:1516068. doi: 10.3389/fimmu.2025.1516068. eCollection 2025.
3
Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: a practical review.过敏与免疫门诊中具有特应性表型的先天性免疫缺陷：实用综述
Curr Opin Allergy Clin Immunol. 2025 Apr 1;25(2):105-114. doi: 10.1097/ACI.0000000000001059. Epub 2025 Feb 13.
4
Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency.病例报告：DOCK8缺陷患者移植时高龄及使用度普利尤单抗的抢先治疗
Front Immunol. 2025 Jan 28;15:1507494. doi: 10.3389/fimmu.2024.1507494. eCollection 2024.
5
A new-disease-causing dominant-negative variant in CARD11 gene in a Chinese case with recurrent fever.一个中国复发性发热病例中 CARD11 基因的新型致病变异体。
Sci Rep. 2024 Oct 16;14(1):24247. doi: 10.1038/s41598-024-71673-z.
6
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.CADINS 疾病中使用度普利尤单抗和奥马珠单抗治疗特应性的管理。
J Clin Immunol. 2024 Jan 17;44(2):48. doi: 10.1007/s10875-023-01636-y.
7
Atopic manifestations of inborn errors of immunity.先天性免疫缺陷的特应性表现。
Curr Opin Allergy Clin Immunol. 2023 Dec 1;23(6):478-490. doi: 10.1097/ACI.0000000000000943. Epub 2023 Sep 26.
8
Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement.针对伴有特应性的免疫缺陷病（IEIs-A）且有皮肤受累情况的个体化治疗。
Front Pediatr. 2023 Mar 22;11:1129249. doi: 10.3389/fped.2023.1129249. eCollection 2023.
9
Autosomal Recessive Inflammatory Skin Disease Caused by a Novel Biallelic Loss-of-Function Variant in CARD11.由CARD11中一种新型双等位基因功能丧失变异引起的常染色体隐性炎症性皮肤病。
J Clin Immunol. 2023 May;43(4):709-713. doi: 10.1007/s10875-023-01440-8. Epub 2023 Feb 2.
10
Genetic/Environmental Contributions and Immune Dysregulation in Children with Atopic Dermatitis.特应性皮炎患儿的遗传/环境因素及免疫失调
J Asthma Allergy. 2022 Nov 23;15:1681-1700. doi: 10.2147/JAA.S293900. eCollection 2022.